Stacher Georg, Abatzi Thalia-Anthi, Schulte Fritz, Schneider Christa, Stacher-Janotta Giselheid, Gaupmann Gabriele, Mittelbach Gerda, Steinringer Hermann
Psychophysiology Unit, University of Vienna, Währinger Gürtel 18-20, A-1090 ViennaAustria Essex Pharma, Sendlinger Strasse 37/1, D-8000 MunichF.R.G.
Pain. 1988 Sep;34(3):271-276. doi: 10.1016/0304-3959(88)90122-4.
It has been hypothesized that, in the absence of acute or chronic pain, a tonically active system exists involving opioid peptides, which ensures a certain level of pain insensitivity. Although various studies have failed to support this concept, it has been reported that in conditions of both experimentally induced and clinical pain, high doses of the opioid antagonist naloxone induced a state of hyperalgesia and thus seemed to set off this hypothetical system. Lower doses were, however, without effect or even acted as analgesics. This study investigated the effect of 5 and 20 mg naloxone i.v., compared to placebo, on the perception of pain in healthy humans. Pain was induced by two methods, using electrical and thermal stimulation of the skin, which have previously been shown to be sensitive to the effects of opioid as well as of non-steroidal anti-inflammatory analgesics. Each of 12 males and 12 females participated in 3 experimental sessions, in which the treatments were administered double-blind according to a Latin square design. Threshold and tolerance to electrically induced pain and threshold to thermally induced pain were measured at 30 min intervals for 90 min before and 90 min after drug administration. Electrical stimuli were square wave constant current impulses of linearly increasing intensity; thermal stimuli were of constant intensity and variable duration. Threshold and tolerance to electrically induced pain were not altered by either dose of naloxone, whereas the threshold to thermally induced pain was significantly higher after both 5 and 20 mg naloxone than after placebo, the effects of the two naloxone doses not differing from each other.(ABSTRACT TRUNCATED AT 250 WORDS)
据推测,在没有急性或慢性疼痛的情况下,存在一个涉及阿片肽的紧张性活动系统,该系统可确保一定程度的疼痛不敏感。尽管各种研究未能支持这一概念,但有报道称,在实验诱导和临床疼痛的情况下,高剂量的阿片拮抗剂纳洛酮会诱发痛觉过敏状态,因此似乎启动了这个假设的系统。然而,较低剂量则没有效果,甚至起到镇痛作用。本研究调查了静脉注射5毫克和20毫克纳洛酮与安慰剂相比,对健康人疼痛感知的影响。通过两种方法诱导疼痛,即对皮肤进行电刺激和热刺激,此前已证明这两种刺激对阿片类药物以及非甾体抗炎镇痛药的作用敏感。12名男性和12名女性分别参加了3次实验,按照拉丁方设计双盲给药。在给药前90分钟和给药后90分钟,每隔30分钟测量一次电诱导疼痛的阈值和耐受性以及热诱导疼痛的阈值。电刺激为强度线性增加的方波恒流脉冲;热刺激强度恒定,持续时间可变。两种剂量的纳洛酮均未改变电诱导疼痛的阈值和耐受性,而5毫克和20毫克纳洛酮给药后热诱导疼痛的阈值均显著高于安慰剂,两种纳洛酮剂量的效果彼此无差异。(摘要截短于250字)